D IAB ETES MELLITUS CERTIF ICATION EXAMINATION
DM G+1
EXAM
A comprehensive practice examination covering diabetes
fundamentals and classification, glucose monitoring,
pharmacologic management, nutrition and lifestyle, acute
and chronic complications, special populations, patient
education, and emerging diabetes technologies - each
question with a detailed answer rationale.
157 Questions · With Actual Solutions
Cognitive Mix: 25% Recall · 55% Application · 20% Analysis · 80% Scenario-Based
2 0 2 0 2 7 E X A M I N A T I O N C Y C L E · A L I G N E D W I T H A D A S TA N D A R D S O F
CARE
,DM G+1 EXAM - 157 Questions with Actual Solutions 2026/2027
DM G+1 EXAM | 157 QUESTIONS | WITH ACTUAL
SOLUTIONS 2026/2027
Comprehensive Certification Preparation Examination - Aligned with 2026-2027 Diabetes
Management and Certification Standards (ADA Standards of Care)
Table of Contents
Examination Overview and Blueprint 2
Comprehensive Diabetes Mellitus Certification Preparation 1
,DM G+1 EXAM - 157 Questions with Actual Solutions 2026/2027
Examination Overview and Blueprint
This examination contains exactly 157 multiple-choice questions organized into nine content domains,
designed to mirror the rigor, blueprint weighting, and clinical complexity of 2026/2027 diabetes
certification and advanced practice examinations. Each question provides four options with a single best
answer, a marked correct response, and a comprehensive rationale explaining why the keyed answer is
correct and why each distractor is incorrect. Cognitive distribution is approximately 25% recall, 55%
application, and 20% analysis, and roughly 80% of stems are scenario-based to test clinical decision-making
rather than isolated memorization.
Content reflects current American Diabetes Association Standards of Care, including updated diagnostic
thresholds, cardiorenal-protective pharmacologic sequencing, automated insulin delivery technology, CGM
metrics such as Time in Range and Glucose Management Indicator, and individualized glycemic targets
across special populations. Learners should attempt all questions in sequential order and review rationales
even for correctly answered items, because distractors encode the most frequent examination pitfalls in
insulin kinetics, oral agent mechanisms, acute complication differentiation, and special-population
management.
Section Content Domain Question Range Items
Diabetes Fundamentals and Classification (Types, Epidemiology,
Section 1 Q1 - Q20 20
Pathophysiology, & Diagnostic Criteria)
Glucose Monitoring and Diagnostic Testing (SMBG, CGM, A1C,
Section 2 Q21 - Q35 15
OGTT, & Lab Interpretation)
Pharmacological Management (Insulins, Oral Agents, Injectables,
Section 3 Q36 - Q60 25
& Combination Therapy)
Nutritional Management, Exercise, and Lifestyle (Medical
Section 4 Q61 - Q75 15
Nutrition Therapy, Carbohydrate Counting, & Physical Activity)
Acute Complications (Hypoglycemia, DKA, HHS, & Sick Day
Section 5 Q76 - Q90 15
Management)
Chronic Complications (Microvascular, Macrovascular,
Section 6 Q91 - Q110 20
Neuropathy, Nephropathy, Retinopathy, & Foot Care)
Special Populations and Situations (Pediatrics, Pregnancy,
Section 7 Q111 - Q125 15
Geriatrics, Hospitalized Patients, & Surgery)
Patient Education, Self-Management, and Psychosocial Care
Section 8 Q126 - Q145 20
(DSMES, Behavior Change, Adherence, & Mental Health)
Technology and Emerging Therapies (Insulin Pumps, CGM
Section 9 Q146 - Q157 12
Systems, Closed-Loop Systems, & New Medications)
Total All content domains Q1 - Q157 157
Comprehensive Diabetes Mellitus Certification Preparation 2
, DM G+1 EXAM - 157 Questions with Actual Solutions 2026/2027
Section 1: Diabetes Fundamentals and Classification (Types, Epidemiology,
Pathophysiology, & Diagnostic Criteria)
Questions 1 through 20
Q1: A 22-year-old previously healthy college student presents with polyuria, polydipsia, and an
unintentional 8-kg weight loss over the past 6 weeks. His random plasma glucose is 385 mg/dL and
urinalysis shows moderate ketonuria. Which pathophysiologic process is the PRIMARY cause of this
presentation?
A. Insulin resistance with compensatory hyperinsulinemia
B. Autoimmune T-cell-mediated destruction of pancreatic beta cells resulting in absolute
insulin deficiency [CORRECT]
C. Progressive amyloid deposition in islets causing gradual beta-cell dysfunction
D. Excessive primary hepatic glucagon secretion with preserved insulin release
Correct Answer: B
Rationale: The rapid onset, marked weight loss, severe hyperglycemia, and ketonuria in a young adult are
hallmark features of type 1 diabetes, in which autoreactive CD4+ and CD8+ T cells destroy pancreatic beta
cells, producing absolute insulin deficiency. Without insulin, unopposed glucagon and catecholamines drive
lipolysis, hepatic ketogenesis, and gluconeogenesis, which explains both the ketonuria and the catabolic weight
loss. Options A and C describe type 2 diabetes mechanisms, in which residual insulin secretion usually
prevents ketosis for years. Option D is incorrect because glucagon excess in type 1 diabetes is a secondary
consequence of absent intra-islet insulin signaling, not a primary endocrine tumor-like process.
Q2: A clinician suspects type 1 diabetes in a 30-year-old patient with new-onset hyperglycemia.
Which laboratory finding is MOST specific for confirming autoimmune destruction of the
pancreatic beta cells?
A. Elevated fasting C-peptide concentration
B. Fasting plasma glucose of 250 mg/dL or higher
C. Positive GAD-65, IA-2, or ZnT8 islet autoantibodies [CORRECT]
D. Elevated fasting insulin level with normal C-peptide
Correct Answer: C
Rationale: Islet autoantibodies such as GAD-65, IA-2, ZnT8, and insulin autoantibodies directly indicate the
immune-mediated beta-cell destruction that defines type 1 diabetes, and positivity for any single antibody
already substantially raises disease risk. C-peptide is typically low in type 1 diabetes, and an elevated fasting
insulin with normal C-peptide suggests insulin resistance rather than autoimmunity. A glucose of 250 mg/dL
only confirms hyperglycemia and cannot distinguish type 1 from type 2 or secondary diabetes. Therefore,
antibody testing is the most etiology-specific choice listed.
Comprehensive Diabetes Mellitus Certification Preparation 3
DM G+1
EXAM
A comprehensive practice examination covering diabetes
fundamentals and classification, glucose monitoring,
pharmacologic management, nutrition and lifestyle, acute
and chronic complications, special populations, patient
education, and emerging diabetes technologies - each
question with a detailed answer rationale.
157 Questions · With Actual Solutions
Cognitive Mix: 25% Recall · 55% Application · 20% Analysis · 80% Scenario-Based
2 0 2 0 2 7 E X A M I N A T I O N C Y C L E · A L I G N E D W I T H A D A S TA N D A R D S O F
CARE
,DM G+1 EXAM - 157 Questions with Actual Solutions 2026/2027
DM G+1 EXAM | 157 QUESTIONS | WITH ACTUAL
SOLUTIONS 2026/2027
Comprehensive Certification Preparation Examination - Aligned with 2026-2027 Diabetes
Management and Certification Standards (ADA Standards of Care)
Table of Contents
Examination Overview and Blueprint 2
Comprehensive Diabetes Mellitus Certification Preparation 1
,DM G+1 EXAM - 157 Questions with Actual Solutions 2026/2027
Examination Overview and Blueprint
This examination contains exactly 157 multiple-choice questions organized into nine content domains,
designed to mirror the rigor, blueprint weighting, and clinical complexity of 2026/2027 diabetes
certification and advanced practice examinations. Each question provides four options with a single best
answer, a marked correct response, and a comprehensive rationale explaining why the keyed answer is
correct and why each distractor is incorrect. Cognitive distribution is approximately 25% recall, 55%
application, and 20% analysis, and roughly 80% of stems are scenario-based to test clinical decision-making
rather than isolated memorization.
Content reflects current American Diabetes Association Standards of Care, including updated diagnostic
thresholds, cardiorenal-protective pharmacologic sequencing, automated insulin delivery technology, CGM
metrics such as Time in Range and Glucose Management Indicator, and individualized glycemic targets
across special populations. Learners should attempt all questions in sequential order and review rationales
even for correctly answered items, because distractors encode the most frequent examination pitfalls in
insulin kinetics, oral agent mechanisms, acute complication differentiation, and special-population
management.
Section Content Domain Question Range Items
Diabetes Fundamentals and Classification (Types, Epidemiology,
Section 1 Q1 - Q20 20
Pathophysiology, & Diagnostic Criteria)
Glucose Monitoring and Diagnostic Testing (SMBG, CGM, A1C,
Section 2 Q21 - Q35 15
OGTT, & Lab Interpretation)
Pharmacological Management (Insulins, Oral Agents, Injectables,
Section 3 Q36 - Q60 25
& Combination Therapy)
Nutritional Management, Exercise, and Lifestyle (Medical
Section 4 Q61 - Q75 15
Nutrition Therapy, Carbohydrate Counting, & Physical Activity)
Acute Complications (Hypoglycemia, DKA, HHS, & Sick Day
Section 5 Q76 - Q90 15
Management)
Chronic Complications (Microvascular, Macrovascular,
Section 6 Q91 - Q110 20
Neuropathy, Nephropathy, Retinopathy, & Foot Care)
Special Populations and Situations (Pediatrics, Pregnancy,
Section 7 Q111 - Q125 15
Geriatrics, Hospitalized Patients, & Surgery)
Patient Education, Self-Management, and Psychosocial Care
Section 8 Q126 - Q145 20
(DSMES, Behavior Change, Adherence, & Mental Health)
Technology and Emerging Therapies (Insulin Pumps, CGM
Section 9 Q146 - Q157 12
Systems, Closed-Loop Systems, & New Medications)
Total All content domains Q1 - Q157 157
Comprehensive Diabetes Mellitus Certification Preparation 2
, DM G+1 EXAM - 157 Questions with Actual Solutions 2026/2027
Section 1: Diabetes Fundamentals and Classification (Types, Epidemiology,
Pathophysiology, & Diagnostic Criteria)
Questions 1 through 20
Q1: A 22-year-old previously healthy college student presents with polyuria, polydipsia, and an
unintentional 8-kg weight loss over the past 6 weeks. His random plasma glucose is 385 mg/dL and
urinalysis shows moderate ketonuria. Which pathophysiologic process is the PRIMARY cause of this
presentation?
A. Insulin resistance with compensatory hyperinsulinemia
B. Autoimmune T-cell-mediated destruction of pancreatic beta cells resulting in absolute
insulin deficiency [CORRECT]
C. Progressive amyloid deposition in islets causing gradual beta-cell dysfunction
D. Excessive primary hepatic glucagon secretion with preserved insulin release
Correct Answer: B
Rationale: The rapid onset, marked weight loss, severe hyperglycemia, and ketonuria in a young adult are
hallmark features of type 1 diabetes, in which autoreactive CD4+ and CD8+ T cells destroy pancreatic beta
cells, producing absolute insulin deficiency. Without insulin, unopposed glucagon and catecholamines drive
lipolysis, hepatic ketogenesis, and gluconeogenesis, which explains both the ketonuria and the catabolic weight
loss. Options A and C describe type 2 diabetes mechanisms, in which residual insulin secretion usually
prevents ketosis for years. Option D is incorrect because glucagon excess in type 1 diabetes is a secondary
consequence of absent intra-islet insulin signaling, not a primary endocrine tumor-like process.
Q2: A clinician suspects type 1 diabetes in a 30-year-old patient with new-onset hyperglycemia.
Which laboratory finding is MOST specific for confirming autoimmune destruction of the
pancreatic beta cells?
A. Elevated fasting C-peptide concentration
B. Fasting plasma glucose of 250 mg/dL or higher
C. Positive GAD-65, IA-2, or ZnT8 islet autoantibodies [CORRECT]
D. Elevated fasting insulin level with normal C-peptide
Correct Answer: C
Rationale: Islet autoantibodies such as GAD-65, IA-2, ZnT8, and insulin autoantibodies directly indicate the
immune-mediated beta-cell destruction that defines type 1 diabetes, and positivity for any single antibody
already substantially raises disease risk. C-peptide is typically low in type 1 diabetes, and an elevated fasting
insulin with normal C-peptide suggests insulin resistance rather than autoimmunity. A glucose of 250 mg/dL
only confirms hyperglycemia and cannot distinguish type 1 from type 2 or secondary diabetes. Therefore,
antibody testing is the most etiology-specific choice listed.
Comprehensive Diabetes Mellitus Certification Preparation 3
